Zoetis Inc. (NYSE:ZTS) Shares Bought by Financial Counselors Inc.

Financial Counselors Inc. grew its holdings in Zoetis Inc. (NYSE:ZTS) by 5.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 155,696 shares of the company’s stock after acquiring an additional 8,526 shares during the quarter. Financial Counselors Inc.’s holdings in Zoetis were worth $30,420,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of ZTS. Silvercrest Asset Management Group LLC boosted its stake in Zoetis by 33.3% in the 1st quarter. Silvercrest Asset Management Group LLC now owns 12,793 shares of the company’s stock worth $2,165,000 after purchasing an additional 3,193 shares in the last quarter. Kennedy Capital Management LLC purchased a new stake in shares of Zoetis during the first quarter valued at $883,000. Tidal Investments LLC increased its position in shares of Zoetis by 9.8% in the 1st quarter. Tidal Investments LLC now owns 8,703 shares of the company’s stock valued at $1,471,000 after acquiring an additional 776 shares during the period. LRI Investments LLC purchased a new position in Zoetis in the 1st quarter worth $43,000. Finally, Orleans Capital Management Corp LA lifted its position in Zoetis by 50.6% during the 1st quarter. Orleans Capital Management Corp LA now owns 8,041 shares of the company’s stock worth $1,361,000 after acquiring an additional 2,700 shares during the period. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Wall Street Analyst Weigh In

ZTS has been the subject of several research analyst reports. JPMorgan Chase & Co. raised their price objective on Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Piper Sandler lifted their price objective on shares of Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, August 14th. BTIG Research increased their price objective on shares of Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, August 12th. Stifel Nicolaus boosted their target price on shares of Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research report on Wednesday, September 18th. Finally, Argus raised Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. Ten analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $221.44.

Zoetis Trading Up 0.6 %

ZTS stock opened at $176.74 on Thursday. Zoetis Inc. has a 52-week low of $144.80 and a 52-week high of $201.92. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26. The firm has a market cap of $79.74 billion, a P/E ratio of 33.22, a PEG ratio of 2.70 and a beta of 0.90. The company’s 50-day simple moving average is $184.51 and its 200-day simple moving average is $180.81.

Zoetis (NYSE:ZTS) last issued its quarterly earnings data on Monday, November 4th. The company reported $1.58 EPS for the quarter, beating the consensus estimate of $1.46 by $0.12. The company had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.29 billion. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. Zoetis’s quarterly revenue was up 11.6% compared to the same quarter last year. During the same period last year, the company earned $1.36 earnings per share. As a group, equities analysts forecast that Zoetis Inc. will post 5.9 EPS for the current fiscal year.

Zoetis Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 3rd. Shareholders of record on Thursday, October 31st will be given a dividend of $0.432 per share. This represents a $1.73 dividend on an annualized basis and a yield of 0.98%. The ex-dividend date of this dividend is Thursday, October 31st. Zoetis’s dividend payout ratio is presently 32.52%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.